PMD Healthcare Inc.
Personal spirometer helps patients with obstructive lung diseases
This article was originally published in Start Up
Executive Summary
The current tool by which patients with lungs diseases (like asthma and COPD) measure their own lung function at home, the peak expiratory flow meter, is not sufficiently informative enough to guide decision-making. PMD Healthcare aims to help respiratory patients care for their disease better. The company has developed a spirometer for home use, Spiro PD, that works on the same principles as the well-accepted office-based and hospital spirometers, but is easy to use and affordable.
You may also be interested in...
COPD Post-Market Requirements: Cardiovascular Safety Could Evolve to Comparative Trials
Forest's aclidinium breezed through an advisory committee review with three strong votes in favor of approval. The FDA panel, however, also included an interesting call for more head-to-head trials in COPD from the outgoing panel chair. That may impact Forest's Phase IV work--but more importantly it may be a sign of the future expectations for other sponsors in the active COPD development area.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.